Almost two-thirds of the world's population could be left without access to a Covid-19 vaccine for the near future, a major non-profit charity group warned in a damning statement.
"Wealthy nations representing just 13 per cent of the world's population have already cornered more than half (51 per cent) of the promised doses of leading Covid-19 vaccine candidates", the report said.
Oxfam is part of the People's Vaccine Alliance, a coalition calling for a jab that is based on shared knowledge and is freely available everywhere.
Oxfam is warning that there is now not enough capacity for pharmaceutical companies to make enough vaccines for everyone who needs one.
Using data from Airfinity, it established the spread of vaccine deals based on information from the manufacturers of five of the leading candidates now in the final stage of clinical trials. The company has said it intends to make a profit from its vaccine and has sold the options for all of its supply to rich nations - at prices that range from $12-16 per dose in the U.S. to around $35 per dose for other countries - putting protection out of reach for many people living in poverty.
It is a platform that will support the research, development, and manufacturing of a wide range of Covid-19 vaccine candidates that aims to deliver two billion doses of safe and effective vaccines by the end of 2021, which should be enough to protect high-risk and vulnerable people, as well as frontline healthcare workers. Developed countries including the UK, US, Australia, Hong Kong & Macau, Japan, Switzerland and Israel, as well as the European Union, have agreed supply deals with pharma companies to secure 2.728 billion doses of Covid-19 vaccines, representing 51% of the current capacity.
Developing nations China, Indonesia, Mexico, India, Bangladesh, and, Brazil have been promised 2.6 billion doses of the vaccine. This includes Gamaleya/Sputnik, Pfizer, AstraZeneca, Moderna and Sinovac.
"We urge the MOH to be transparent on its plans to acquire vaccines for the country".
The report said that the United Kingdom has managed to secure deals equal to five doses per person of the country's population.
Oxfam noted that AstraZeneca has pledged two-thirds of the doses it produces to developing countries.
On Sept 3, health news portal Code Blue reported that Malaysia has not committed to joining a global Covid-19 vaccine allocation plan, co-led by the WHO.
There are hopes Governments, pharmaceutical companies and vaccine producers produce a vaccine that is free to all.
Therefore Oxfam and other similar organisations across the world are calling for a People's Vaccine, that can be availed by everyone and is free of charge being distributed fairly based on the requirement. No single corporation will ever be able to meet the world's need for a COVID-19 vaccine.